Navigation Links
New Data Published in Immunobiology Describe Mode of Action of BiTE Antibody MT110
Date:1/28/2009

contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking statements include statements regarding the efficacy and intended utilization of our product candidates and the development of our BiTE antibody technology. You are urged to consider statements that include the words "may," "potential," or the negative of those words or other similar words to be uncertain and forward-looking. Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that product candidates that appeared promising in early research, preclinical studies or clinical trials do not demonstrate safety and/or efficacy in subsequent clinical trials, the risk that encouraging results from early research, preclinical studies or clinical trials may not be confirmed upon further analysis of the detailed results of such research, preclinical study or clinical trial, and the risk that additional information relating to the safety, efficacy or tolerability of our product candidates may be discovered upon further analysis of preclinical or clinical trial data. These factors and others are more fully discussed in Micromet's Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2008, filed with the SEC on November 6, 2008, as well as other filings by the company with the SEC.

Any forward-looking statements are made pursuant to Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and, as such, speak only as of the date made. Micromet, Inc. undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

(1) Ha
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Published reports inaccurate concerning alcohol consumption during pregnancy
2. Pexiganan Phase 3 Clinical Trials Results Published in December Issue of CID
3. New Guidebook Published for Improving B2B Sales Results in 90 Days or Less Through Kaizen Events
4. Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
5. New Requirements of EU Medical Device Directive Need Immediate Action, Nerac Analysts Urge in Newly Published White Paper
6. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
7. First Study of War-Related Mental Disorders Among Iraqis 10 Years Post-Gulf War Published by Researchers at Wayne State University and Basrah University, Iraq
8. Long-Term Results of VisionCares Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of Ophthalmology
9. Results From Pre-Election Surveys Published in NEJM Show Deep Concerns About State of Health Care With McCain and Obama Supporters Differing Sharply on Directions for New Administration
10. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
11. International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... August 27, 2015 , ... More destinations and stores are becoming pet-friendly, ... Amica Insurance is sharing some tips to help your whole family travel safely and ... travel with pets each year. Amica is sharing the following tips from the American ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... for quality market research promotion on the Internet. MarketPublishers.com is now authorised ... Commenting on the partnership agreement, Natalie Aster, Assistant Manager at Partners Department, ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... Hope and Innovation has grown to having twelve offices in three counties, LA, ... hospitals in the Southern California region. Founded by Dr. Richy Agajanian, the ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... firm that helps libraries, publishers and companies leverage key operational, technical, business ... the VIVO Project. Gunter Media Group, Inc., will provide VIVO related services ...
(Date:8/27/2015)... ... ... An inventor from Gibertsville, Pa., knows how knees can get in the way ... trying to sleep," he said, "so I decided that there needs to be a ... KNEE GUARD helps a user get a better sleep by preventing the knees from ...
Breaking Medicine News(10 mins):Health News:Amica Unleashes 5 Tips for Safe Traveling with Pets 2Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 2Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 3Health News:California’s Largest Private Oncology Practice Serves 50,000 Patients in 8 years 2Health News:DuraSpace Selects Gunter Media Group, Inc. as a Registered Service Provider for VIVO 2Health News:DuraSpace Selects Gunter Media Group, Inc. as a Registered Service Provider for VIVO 3
... University Medical School in Durham, North Carolina and colleagues have ... pain. Patients who use religion or spirituality to cope with ... and boost their sense of well being, the researchers say. ... with chronic illness or chronic pain might find it difficult ...
... liver can injure the donor, it is now established without doubt ... to a person needing it. And the good news is that ... part of his/her liver. ,Donation of a piece of the ... new procedure. It is increasingly being performed in the West where ...
... research-cum-manufacturing agreement between Chiron Corp, the US-based vaccine major, ... potential AIDS vaccine to halt the spread of the ... stage of finalisation. ,Two Hyderabad-based biotechnology/pharma companies -- ... front-runners for the proposed project, which entails an upfront ...
... of the American Association of Endodontists in New Orleans, Louisiana, ... terse message, the dentists said that all toothache need not ... because it may be the early warning for more important ... hygiene has never received its due importance from the masses. ...
... the British government says that smoking will turn out to ... the threat of even HIV. The British broadcasting corporation reported ... more people than any other disease in the next 20 ... in Sussex, United Kingdom, says smoking and other tobacco related ...
... up to 3 million lives a year. WHO released a ... March. The report says most of those who die are ... the developing world are particularly at risk for water-borne diseases. ... contaminated water and 90% of those deaths are among children ...
Cached Medicine News:Health News:Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos 2
(Date:8/27/2015)... Aug. 27, 2015 WuXi PharmaTech (Cayman) Inc. ... technology platform company serving the pharmaceutical, biotechnology, ... process development and manufacturing subsidiary Shanghai SynTheAll ... approval from the Japan PMDA for the ... branded commercial drug in July. STA is ...
(Date:8/27/2015)... CAMBRIDGE, Mass. , Aug. 27, 2015 Oryzon ... & Renshaw 17th Annual Global Investment Conference in ... Hotel, ORYZON will be represented by President and CEO ... Dr. Buesa will present this information on Thursday September ... (2nd Floor).  The company is completing preclinical development of its ...
(Date:8/26/2015)... NEW YORK , Aug. 26, 2015 The ... a CAGR of 7.0% between 2014 and 2019. Although ... Computerized Physician Order Entry market, India ... the forecast period in this regional market. The increasing demand ... government bodies for implementation of these systems in healthcare facilities ...
Breaking Medicine Technology:WuXi PharmaTech's STA Subsidiary Receives First Approval from Japanese Regulatory Authorities 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 3ORYZON to Present at Rodman & Renshaw 17th Annual Global Investment Conference 4Asian Computerized Physician Order Entry Market by Product, by Deployment, by Component -Forecast to 2019 2Asian Computerized Physician Order Entry Market by Product, by Deployment, by Component -Forecast to 2019 3
... vitro microbiology and proof of concept in topical ... March 2007 - Arpida Ltd.,(SWX: ARPN) today announced ... against a large panel of,clinical isolates, including those ... of AR-2474 were found,to be highly effective in ...
... Autism Association calls 2006 Pediatrics study fatally,flawed, CHICAGO, ... at a National Autism Association meeting,bolster claims that ... of,autism spectrum disorders. David Ayoub, MD presented data,suggesting ... pervasive developmental disorder (PDD), a form of autism,in ...
Cached Medicine Technology:Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 2Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 3Newly Released Canadian Data Links Vaccines with Pervasive,Developmental Disorder 2
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... The Blue Line UNO Splint fits small, medium, ... cushioned two-part design includes both dorsal and volar ... extension. Recommended for those experiencing symptoms of Carpal ... for busy clinics - stock one splint to ...
Comfort Wrist Immobilizer with thumb abduction. 8"L, soft, padded comfort-type wrist immobilizer with dorsal metal stay. The thumb is held in abduction and splintered with a short metal stay....
Medicine Products: